Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Lung Cancer

Free Subscription 01.02.2010 1 Am J Clin Pathol 1 Am J Respir Crit Care Med 3 Ann Thorac Surg 2 Arch Bronconeumol 1 BMJ 1 Br J Cancer 2 Cancer 1 Cancer Chemother Pharmacol 4 Carcinogenesis 1 J Clin Invest 5 J Clin Oncol 17 J Thorac Oncol 3 Lung Cancer

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Clin Pathol

1. GARFIELD D
   Mucinous and nonmucinous bronchioloalveolar carcinoma and smoking.
   Am J Clin Pathol. 2010;133:341-2.
   PubMed     Text format     Related articles   
   
   

   
   Am J Respir Crit Care Med

2. BUNN PA JR
   Optimal therapy for elderly patients with early stage non-small cell lung cancer.
   Am J Respir Crit Care Med. 2010;181:201-2.
   PubMed     Text format     Related articles   
   
   

   
   Ann Thorac Surg

3. BLASBERG JD , Belsley SJ, Schwartz GS, Evans A, et al
   Robotic brachytherapy and sublobar resection for T1 non-small cell lung cancer in high-risk patients.
   Ann Thorac Surg. 2010;89:360-7.
   PubMed     Text format     Related articles    Abstract available
   
   
4. YAMAMOTO K , Ohsumi A, Kojima F, Imanishi N, et al
   Long-term survival after video-assisted thoracic surgery lobectomy for primary lung cancer.
   Ann Thorac Surg. 2010;89:353-9.
   PubMed     Text format     Related articles    Abstract available
   
   
5. KRASNA MJ , Gamliel Z, Burrows WM, Sonett JR, et al
   Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation.
   Ann Thorac Surg. 2010;89:200-6.
   PubMed     Text format     Related articles    Abstract available
   
   

   
   Arch Bronconeumol

6. SORIANO JB
   [Mortality in Lung Cancer and COPD.]
   Arch Bronconeumol. 2010.
   PubMed     Text format     Related articles   
   
   
7. LUCILLI N , Mattacheo A, Palacios A
   [Acrometastasis Due to Lung Cancer. A Case Presentation.]
   Arch Bronconeumol. 2010.
   PubMed     Text format     Related articles   
   
   

   
   BMJ

8. PARSONS A , Daley A, Begh R, Aveyard P, et al
   Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis.
   BMJ. 2010;340:b5569.
   PubMed     Text format     Related articles    Abstract available
   
   

   
   Br J Cancer

9. PUGLISI M , Dolly S, Faria A, Myerson JS, et al
   Treatment options for small cell lung cancer - do we have more choice?
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   

   
   Cancer

10. WANG T , Nelson RA, Bogardus A, Grannis FW Jr, et al
    Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival?
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
11. OXNARD GR , Schwartz LH
    Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    

    
    Cancer Chemother Pharmacol

12. LAM ET , Au JL, Otterson GA, Guillaume Wientjes M, et al
    Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.
    Cancer Chemother Pharmacol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Carcinogenesis

13. HSU YL , Hung JY, Ko YC, Hung CH, et al
    Phospholipase D signaling pathway is involved in lung cancer-derived IL-8 increased osteoclastogenesis.
    Carcinogenesis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
14. TRUONG T , Sauter W, McKay JD, Hosgood HD 3rd, et al
    International Lung Cancer Consortium: Coordinated association study of 10 potential lung cancer susceptibility variants.
    Carcinogenesis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
15. ZHANG Z , Kobayashi S, Borczuk AC, Leidner RS, et al
    Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK-signaling in lung cancer cells.
    Carcinogenesis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
16. PARK JY , Matsuo K, Suzuki T, Ito H, et al
    Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 (ALDH2) null allele in a Japanese population.
    Carcinogenesis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    J Clin Invest

17. LIN RK , Hsieh YS, Lin P, Hsu HS, et al
    The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients.
    J Clin Invest. 2010 Jan 19. pii: 40706. doi: 10.1172/JCI40706.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    J Clin Oncol

18. FRIEDEL G , Budach W, Dippon J, Spengler W, et al
    Phase II Trial of a Trimodality Regimen for Stage III Non-Small-Cell Lung Cancer Using Chemotherapy As Induction Treatment With Concurrent Hyperfractionated Chemoradiation With Carboplatin and Paclitaxel Followed by Subsequent Resection: A Single-Cent
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
19. LYNCH TJ , Patel T, Dreisbach L, McCleod M, et al
    Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non-Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
20. KHAMBATA-FORD S , Harbison CT, Hart LL, Awad M, et al
    Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
21. SHEPHERD FA , Tsao MS
    Epidermal Growth Factor Receptor Biomarkers in Non-Small-Cell Lung Cancer: A Riddle, Wrapped in a Mystery, Inside an Enigma.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
22. ARAUJO AM
    Pemetrexed Plus Bevacizumab for Second-Line Therapy of Non-Small-Cell Lung Cancer: The Importance of Patient Selection.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    

    
    J Thorac Oncol

23. CHIAPPORI AA , Zheng Z, Chen T, Rawal B, et al
    Features of Potentially Predictive Biomarkers of Chemotherapeutic Efficacy in Small Cell Lung Cancer.
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
24. SONG WA , Zhou NK, Wang W, Chu XY, et al
    Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials.
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
25. JEON HS , Jen J
    TGF-beta Signaling and the Role of Inhibitory Smads in Non-small Cell Lung Cancer.
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
26. GO H , Jeon YK, Park HJ, Sung SW, et al
    High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer.
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
27. LEE YJ , Kim HT, Han JY, Yun T, et al
    First-Line Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status.
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
28. SKOV BG , Holm B, Erreboe A, Skov T, et al
    ERCC1 and Ki67 in Small Cell Lung Carcinoma and Other Neuroendocrine Tumors of the Lung: Distribution and Impact on Survival.
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
29. KIM H , Ahn YC, Park HC, Lim DH, et al
    Results and Prognostic Factors of Hypofractionated Stereotactic Radiation Therapy for Primary or Metastatic Lung Cancer.
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
30. WU CH , Fan WC, Chen YM, Chou KT, et al
    Second-Line Therapy for Elderly Patients with Non-small Cell Lung Cancer Who Failed Previous Chemotherapy Is as Effective as for Younger Patients.
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
31. PARK JS , Yang HC, Kim HK, Kim K, et al
    Sleeve Lobectomy as an Alternative Procedure to Pneumonectomy for Non-small Cell Lung Cancer.
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
32. LOPEZ-ENCUENTRA A , Duque-Medina JL, Rami-Porta R
    Persistent confusion on the clinical and pathologic nodal staging in lung cancer.
    J Thorac Oncol. 2010;5:285-6.
    PubMed     Text format     Related articles   
    
    
33. GOFFIN J , Lacchetti C, Ellis PM, Ung YC, et al
    First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review.
    J Thorac Oncol. 2010;5:260-74.
    PubMed     Text format     Related articles    Abstract available
    
    
34. PETRELLA F , Rizzo S, Solli P, Borri A, et al
    Intraparenchymal pulmonary artery aneurysm from ipsilobar non-small cell lung cancer.
    J Thorac Oncol. 2010;5:258-9.
    PubMed     Text format     Related articles   
    
    
35. SINGH N , Aggarwal AN, Behera D, Jindal SK, et al
    Intercycle delays during chemotherapy of non-small cell lung cancer in a health care resource-constrained setting and their effect on overall survival.
    J Thorac Oncol. 2010;5:236-9.
    PubMed     Text format     Related articles    Abstract available
    
    
36. YU JB , Decker RH, Detterbeck FC, Wilson LD, et al
    Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer.
    J Thorac Oncol. 2010;5:215-9.
    PubMed     Text format     Related articles    Abstract available
    
    
37. HOTTA K , Kiura K, Takigawa N, Yoshioka H, et al
    Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese Patients with non-small cell lung cancer: the Okayama Lung Cancer Study Group experience.
    J Thorac Oncol. 2010;5:179-84.
    PubMed     Text format     Related articles    Abstract available
    
    
38. SHEPHERD FA
    Surgery for limited stage small cell lung cancer: time to fish or cut bait.
    J Thorac Oncol. 2010;5:147-9.
    PubMed     Text format     Related articles   
    
    
39. DHILLON T , Mauri FA, Bellezza G, Cagini L, et al
    Overexpression of the Mammalian Target of Rapamycin: A Novel Biomarker for Poor Survival in Resected Early Stage Non-small Cell Lung Cancer.
    J Thorac Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

    
    Lung Cancer

40. SURMONT V , Smit EF, de Jonge M, Aerts JG, et al
    Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: Results from 2 phase I studies.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
41. KIM HS , Lee GW, Kim JH, Kim HY, et al
    A phase II study of pemetrexed and carboplatin as a salvage therapy for platinum-pretreated patients with non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
42. DOEBELE RC , Oton AB, Peled N, Camidge DR, et al
    New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer.
    Lung Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: